Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus - PubMed (original) (raw)
Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus
P Borrow et al. Nat Med. 1997 Feb.
Abstract
The HIV-1-specific cytotoxic T lymphocyte (CTL) response is temporally associated with the decline in viremia during primary HIV-1 infection, but definitive evidence that it is of importance in virus containment has been lacking. Here we show that in a patient whose early CTL response was focused on a highly immunodominant epitope in gp 160, there was rapid elimination of the transmitted virus strain and selection for a virus population bearing amino acid changes at a single residue within this epitope, which conferred escape from recognition by epitope-specific CTL. The magnitude (> 100-fold), kinetics (30-72 days from onset of symptoms) and genetic pathways of virus escape from CTL pressure were comparable to virus escape from antiretroviral therapy, indicating the biological significance of the CTL response in vivo. One aim of HIV-1 vaccines should thus be to elicit strong CTL responses against multiple codominant viral epitopes.
Comment in
- A naturally unbalanced combat [new; comment].
Zagury D. Zagury D. Nat Med. 1997 Feb;3(2):156-7. doi: 10.1038/nm0297-156. Nat Med. 1997. PMID: 9018232 No abstract available.
Similar articles
- Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response.
Jones NA, Wei X, Flower DR, Wong M, Michor F, Saag MS, Hahn BH, Nowak MA, Shaw GM, Borrow P. Jones NA, et al. J Exp Med. 2004 Nov 15;200(10):1243-56. doi: 10.1084/jem.20040511. J Exp Med. 2004. PMID: 15545352 Free PMC article. - Role of cytotoxic T-lymphocyte-mediated immune selection in a dominant human leukocyte antigen-B8-restricted cytotoxic T-lymphocyte epitope in Nef.
Maurer K, Harrer EG, Goldwich A, Eismann K, Bergmann S, Schmitt-Haendle M, Spriewald B, Mueller SM, Harrer T; German Competence Network for HIV/AIDS. Maurer K, et al. J Acquir Immune Defic Syndr. 2008 Jun 1;48(2):133-41. doi: 10.1097/QAI.0b013e31816fdc4a. J Acquir Immune Defic Syndr. 2008. PMID: 18391752 - Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS.
Goulder PJ, Phillips RE, Colbert RA, McAdam S, Ogg G, Nowak MA, Giangrande P, Luzzi G, Morgan B, Edwards A, McMichael AJ, Rowland-Jones S. Goulder PJ, et al. Nat Med. 1997 Feb;3(2):212-7. doi: 10.1038/nm0297-212. Nat Med. 1997. PMID: 9018241 - Escape of human immunodeficiency virus from immune control.
McMichael AJ, Phillips RE. McMichael AJ, et al. Annu Rev Immunol. 1997;15:271-96. doi: 10.1146/annurev.immunol.15.1.271. Annu Rev Immunol. 1997. PMID: 9143689 Review. - Co-evolution of human immunodeficiency virus and cytotoxic T-lymphocyte responses.
Goulder P, Price D, Nowak M, Rowland-Jones S, Phillips R, McMichael A. Goulder P, et al. Immunol Rev. 1997 Oct;159:17-29. doi: 10.1111/j.1600-065x.1997.tb01004.x. Immunol Rev. 1997. PMID: 9416500 Review.
Cited by
- Energy demanding RNA and protein metabolism drive dysfunctionality of HIV-specific T cell changes during chronic HIV infection.
van Pul L, Stunnenberg M, Kroeze S, van Dort KA, Boeser-Nunnink BDM, Harskamp AM, Geijtenbeek TBH, Kootstra NA. van Pul L, et al. PLoS One. 2024 Oct 2;19(10):e0298472. doi: 10.1371/journal.pone.0298472. eCollection 2024. PLoS One. 2024. PMID: 39356699 Free PMC article. - Messenger RNA Vaccine Technology: Success for SARS-CoV-2 and Prospects for an HIV-1 Vaccine.
Files JK, Goepfert PA. Files JK, et al. Top Antivir Med. 2024 Apr 18;32(2):420-430. Top Antivir Med. 2024. PMID: 39141920 Free PMC article. Review. - Differences in HIV-1 reservoir size, landscape characteristics and decay dynamics in acute and chronic treated HIV-1 Clade C infection.
Reddy K, Lee GQ, Reddy N, Chikowore TJB, Baisley K, Dong K, Walker BD, Yu XG, Lichterfeld M, Ndung'u T. Reddy K, et al. medRxiv [Preprint]. 2024 Oct 9:2024.02.16.24302713. doi: 10.1101/2024.02.16.24302713. medRxiv. 2024. PMID: 38947072 Free PMC article. Preprint. - Immunotoxin-mediated depletion of Gag-specific CD8+ T cells undermines natural control of SIV.
Simpson J, Starke CE, Ortiz AM, Ransier A, Darko S, Llewellyn-Lacey S, Fennessey CM, Keele BF, Douek DC, Price DA, Brenchley JM. Simpson J, et al. JCI Insight. 2024 Jun 17;9(14):e174168. doi: 10.1172/jci.insight.174168. JCI Insight. 2024. PMID: 38885329 Free PMC article. - Current situation in the development of a preventive HIV vaccine.
Alcamí J, Joseph Munné J, Muñoz-Fernández MÁ, Esteban M. Alcamí J, et al. Enferm Infecc Microbiol Clin. 2005 Jul;23:15-24. doi: 10.1016/S0213-005X(05)75157-0. Epub 2009 Jan 6. Enferm Infecc Microbiol Clin. 2005. PMID: 38620211 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical